Date Filer Title Filing Type Shares Traded Price Total Held
Feb 20, 2024
Chief Innovation Officer
Chief Innovation Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 59,377 -- 305,605
Feb 20, 2024
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 59,377 -- 274,993
Nov 30, 2010
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 59,418 $2.92 214,802
Nov 30, 2010
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 59,418 $24.06 155,384
Nov 30, 2010
Director
Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 59,418 -- --
Feb 20, 2024
EVP & Chief Financial Officer
EVP & Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 59,800 -- 423,770
Feb 20, 2024
EVP, Chief Development Officer
EVP, Chief Development Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 59,800 -- 244,071
Feb 20, 2020
Director, President & CEO
Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 60,963 -- 396,509
Feb 19, 2020
Director, President & CEO
Director, President & CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 62,053 $16.76 335,546
Oct 06, 2010
Director
Director Form 4 Open market or private sale of non-derivative or derivative security 62,387 $24.96 641,035

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.